- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03776188
Endoscopic Suturing (ES) Registry
Prospective Registry for Trans-Orifice Endoscopic Suturing Applications
To determine patient outcomes (survival, additional endoscopic or surgical procedures) with an endoscopic suturing technique at predetermined intervals compared to historical controls when applicable.
To evaluate the efficacy, safety, and durability of trans-orifice endoscopic suturing therapy for revision of bariatric procedures as well as study the safety, efficacy, and durability of preventative fixation of GI endoprosthetics.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
To determine patient outcomes (survival, morbidity including hospitalization, additional re-interventions with radiologic, endoscopic or surgical procedures) with endoscopic suturing at predetermined intervals from the last endoscopic suturing procedure or at failure of the endoscopic suturing with conversion to another intervention such as surgery and compared to historical controls when applicable.
To evaluate the efficacy and safety of endoscopic suturing therapy in preventative fixation of stents and bariatric revision.
To collect data on the common use endoscopic suturing therapy in other indications.
This prospective clinical study is a real-world registry and not a randomized controlled trial. Given the conditions commonly treated with endoscopic suturing and the potential lack of equivalent expertise in open, laparoscopic, and trans-oral surgical procedures at all centers, randomization of participants is not possible nor ethical. In addition, there are clinical scenarios where endoscopic therapy with surgical sutures, tissue sealants, and/or endoprosthetics may be appropriate and open and laparoscopic surgical approaches inappropriate from an ethical viewpoint. Given the multitude of currently available minimally invasive approaches to repair, it would be unethical to expose and randomize patients who are suitable for more minimally invasive approaches to a more invasive and inherently more morbid approach.
This outcomes study is external to the subject receiving the medical device treatment. Subjects will receive the medical device treatment regardless of study participation and the surgery is not part of this research. Subjects will be consented prior to their procedure, to obtain basic follow-up information. If the subject provides informed consent to participate in the registry, then site staff will follow the participant's clinical data for the period of the registry. Site staff may also contact the subject(s) during their standard clinic visit or via the telephone and obtain information on: overall health, specific events related to any subsequent surgical, endoscopic, or radiologic interventions, and hospitalizations.
The clinical data will be collected during usual procedure follow-ups. This will include recording patient demographics, medications, testing results, comorbidities, body mass index, and reason for clinical care visit. If during the follow-up period, the subject undergoes additional clinically indicated procedures or hospitalizations for procedure related indications then the site will submit this information to the registry.
All procedures and device use will be performed as clinically indicated and as directed by the treating physician. All information requested as part of this registry will be obtained from clinical data obtained as part of study.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Arkansas
-
Little Rock, Arkansas, Verenigde Staten, 72211
- University of Arkansas
-
-
Florida
-
Jacksonville, Florida, Verenigde Staten, 32224
- Mayo Clinic Jacksonville
-
Jacksonville, Florida, Verenigde Staten, 32256
- Borland Grover Clinic
-
-
Illinois
-
Evanston, Illinois, Verenigde Staten, 60201
- NorthShore University Healthsystem
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21224
- Johns Hopkins Medical Institution
-
-
Missouri
-
Saint Louis, Missouri, Verenigde Staten, 63110
- Washington University
-
-
New York
-
Manhasset, New York, Verenigde Staten, 11030
- Northwell Health
-
New York, New York, Verenigde Staten, 10021
- New York Presbyterian Hospital
-
New York, New York, Verenigde Staten, 10029
- Mount Sinai Hospital
-
-
Pennsylvania
-
Hershey, Pennsylvania, Verenigde Staten, 17033
- Penn State Hershey Medical Center
-
-
Texas
-
Dallas, Texas, Verenigde Staten, 75214
- Methodist Dallas Medical Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Selected to undergo trans-orifice suturing prior to study enrollment
- Age 18+ years
- Patient ASA classification I, II, III, including emergency cases
- Patient willing to provide informed consent, cooperate with post-operative recommendations and follow-up assessment
Exclusion Criteria:
- Patients who do not meet the clinical criteria for trans-orifice suturing
- Under age 18 years
- ASA classification IV
- Unable to provide informed consent
- Unable to participate in follow-up assessments
- Uncorrectable coagulopathy at the time of endoscopic suturing
- Any terminal disease that limits patient's survival to less than one year
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
---|
no groups - observational study
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Dislocation of Stent - distance
Tijdsspanne: Change at 2 weeks, 30 days, 3 months
|
Change in the position measured using distance (centimeters).
|
Change at 2 weeks, 30 days, 3 months
|
Dislocation of Stent - location
Tijdsspanne: Change at 2 weeks, 30 days, 3 months
|
Change in the position measured using location.
Location options: Bridging the GJ anastomosis, Confined to gastric lumen, Bridging the pylorus, Bridging Lower Esophageal Sphincter
|
Change at 2 weeks, 30 days, 3 months
|
Migration Rate of Stent - placement
Tijdsspanne: Change at 2 weeks, 30 days, 3 months
|
Distal from placement over time (yes or no)
|
Change at 2 weeks, 30 days, 3 months
|
Migration Rate of Stent - replaced
Tijdsspanne: Change at 2 weeks, 30 days, 3 months
|
Stent replaced or re-structured over time (yes or no)
|
Change at 2 weeks, 30 days, 3 months
|
Migration Rate of Stent - sutures
Tijdsspanne: Change at 2 weeks, 30 days, 3 months
|
Number of intact Sutures
|
Change at 2 weeks, 30 days, 3 months
|
Migration Rate of Stent - removal
Tijdsspanne: Change at 2 weeks, 30 days, 3 months
|
Days to removal and replacement
|
Change at 2 weeks, 30 days, 3 months
|
Excess Weight Loss
Tijdsspanne: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
|
Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % excess weight lost and absolute terms.
|
Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
|
Total Weight Loss
Tijdsspanne: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
|
Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % total weight loss and absolute terms.
|
Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
|
Medewerkers en onderzoekers
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Jennifer Maranki, MD, Penn State Milton S. Hershey School of Medicine
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- ES Registry 2-682-101
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Chirurgie
-
Tufts Medical CenterRespiratory Motion, Inc.VoltooidMonitoring voor Low Minute Ventilation Post SurgeryVerenigde Staten
-
University of California, San FranciscoE-DA HospitalBeëindigdFarmacokinetiek van statines Pre en Post Gastric Bypass SurgeryVerenigde Staten, Taiwan
-
Europainclinics z.ú.Brno University Hospital; Pavol Jozef Safarik University; Slovak Academy of SciencesVoltooid
-
Universitair Ziekenhuis BrusselMedtronicVoltooidFailed Back Surgery SyndroomBelgië
-
Universitair Ziekenhuis BrusselMedtronicVoltooidFailed Back Surgery SyndroomBelgië
-
Universitair Ziekenhuis Brusselthe eNose companyVoltooidFailed Back Surgery SyndroomBelgië
-
Moens MaartenVoltooidFailed Back Surgery SyndroomBelgië
-
Universitair Ziekenhuis BrusselNevroVoltooidFailed Back Surgery SyndroomBelgië
-
Moens MaartenMedtronicVoltooid
-
Moens MaartenVoltooidFailed Back Surgery SyndroomBelgië